Search Browse Earnings

Moleculin Biotech, Inc. — SlamSEC

Moleculin Biotech, Inc.

Nasdaq:MBRX

Pharmaceutical Preparations·HOUSTON, TX

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$0

FY 2024

Adj. EBITDA

-$29.5M

FY 2024

Net Income

-$29.8M

FY 2024

EPS (Diluted)

-$15.07

FY 2024

Stock Price

$1.98

-3.4%

2026-03-09

52W Range

$1.79 – $33.00

P/E Ratio

-0.1x

Market Cap

$100.8M

Cash

$23.6M

FY 2024

Total Debt

—

Net Cash

$23.6M

FY 2024

Enterprise Value

$77.3M

Debt / EBITDA

0.8x

FY 2024

EV / EBITDA

-2.6x

Employees

—

CEO

Klemp Walter V

CFO

Foster Jonathan P.